Home> Products> insulin responsive genes

{ "products": [ { "_id": "666185c2161afa2274ff4d10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride, Metformin SR , and Pioglitazone", "description": "SEIZMET GP 2 \nGlimepiride (2 mg), Metformin SR (500mg), Pioglitazone (15mg)\nIntroduction to SEIZMET GP 2\nSEIZMET GP 2 is a combination medication that includes Glimepiride 2 mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Pioglitazone 15mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Pioglitazone, SEIZMET GP 2 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Pioglitazone?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that helps improve blood sugar control by increasing the body's sensitivity to insulin. It works by activating PPARγ (peroxisome proliferator-activated receptor gamma) receptors, which regulate the transcription of insulin-responsive genes involved in the control of glucose and lipid metabolism.\n\nBenefits of SEIZMET GP 2\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Pioglitazone enhances insulin sensitivity in peripheral tissues, providing a comprehensive approach to glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET GP 2 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET GP 2 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLipid Profile Improvement: Pioglitazone can improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, offering additional cardiovascular benefits.\nHow to Use SEIZMET GP 2\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET GP 2 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Pioglitazone. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET GP 2 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\n", "price": 154.0, "discountamount": 46.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "TZD", "body", "meal", "Diet", "Order", "EMAIL", "liver", "PPARγ", "water", "amount", "Action", "option", "Support", "pancreas", "Overview", "readings", "biguanide", "overweight", "one tablet", "Guidelines", "neuropathy", "full glass", "retinopathy", "utilization", "information", "Optimal Use", "Adjustments", "Introduction", "best results", "SEIZMET GP 2", "Pioglitazone", "Metformin SR", "sterisonline", "Reduced Risk", "Postprandial", "instructions", "sterispharma", "sulfonylurea", "triglycerides", "effectiveness", "CALL/WHATSAPP", "transcription", "Administration", "obese patients", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glimepiride 2mg", "lipid metabolism", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "weight neutrality", "thiazolidinedione", "excellent adjunct", "Weight Management", "insulin secretion", "peripheral tissues", "modest weight loss", "Recommended Dosage", "healthcare provider", "individual response", "blood sugar control", "insulin sensitivity", "Diabetes Management", "pancreatic beta cells", "HDL cholesterol levels", "combination medication", "cardiovascular disease", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "lifestyle modifications", "complementary mechanisms", "insulin-responsive genes", "type 2 diabetes mellitus", "Lipid Profile Improvement", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Hydrochloride Sustained Release", "peroxisome proliferator-activated receptor gamma) receptors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1443, "imageuri": "https://productimages.withfloats.com/actual/666185c5c06ee12d88cfaefd.png", "tileimageuri": "https://productimages.withfloats.com/tile/666185c5c06ee12d88cfaefd.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:47:46.414Z", "updatedon": "2026-03-13T06:29:28.725Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-metformin-sr-and-pioglitazone/1443", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET GP 2 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET GP 2", "Glimepiride (2mg)", "Metformin SR (500mg)", "Pioglitazone (15mg)", "Pioglitazone side effects", "Pioglitazone 15 mg price", "Side effects of pioglitazone 15 mg", "Is pioglitazone safe", "Pioglitazone uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66618121a743fd2358220c35", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET GP 1 ", "description": "SEIZMET GP 1 \nGlimepiride (1mg), Metformin SR (500mg), Pioglitazone (15mg)\nIntroduction to SEIZMET GP 1\nSEIZMET GP 1 is a combination medication that includes Glimepiride 1mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Pioglitazone 15mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Pioglitazone, SEIZMET GP 1 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Pioglitazone?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that helps improve blood sugar control by increasing the body's sensitivity to insulin. It works by activating PPARγ (peroxisome proliferator-activated receptor gamma) receptors, which regulate the transcription of insulin-responsive genes involved in the control of glucose and lipid metabolism.\n\nBenefits of SEIZMET GP 1\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Pioglitazone enhances insulin sensitivity in peripheral tissues, providing a comprehensive approach to glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET GP 1 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET GP 1 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLipid Profile Improvement: Pioglitazone can improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, offering additional cardiovascular benefits.\nHow to Use SEIZMET GP 1\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET GP 1 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Pioglitazone. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET GP 1 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-gp-1-133442", "price": 144.45, "discountamount": 43.34, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "TZD", "body", "Diet", "Order", "EMAIL", "liver", "PPARγ", "water", "meals", "amount", "Action", "option", "Support", "pancreas", "Overview", "readings", "biguanide", "neuropathy", "one tablet", "full glass", "Guidelines", "overweight", "Optimal Use", "information", "utilization", "Adjustments", "retinopathy", "Metformin SR", "SEIZMET GP 1", "best results", "Pioglitazone", "Introduction", "sterisonline", "Reduced Risk", "Postprandial", "instructions", "sterispharma", "sulfonylurea", "triglycerides", "effectiveness", "CALL/WHATSAPP", "transcription", "Administration", "obese patients", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glimepiride 1mg", "lipid metabolism", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "weight neutrality", "thiazolidinedione", "excellent adjunct", "Weight Management", "insulin secretion", "peripheral tissues", "modest weight loss", "Recommended Dosage", "healthcare provider", "individual response", "blood sugar control", "insulin sensitivity", "Diabetes Management", "pancreatic beta cells", "HDL cholesterol levels", "combination medication", "cardiovascular disease", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "lifestyle modifications", "complementary mechanisms", "insulin-responsive genes", "type 2 diabetes mellitus", "Lipid Profile Improvement", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Hydrochloride Sustained Release", "peroxisome proliferator-activated receptor gamma) receptors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1440, "imageuri": "https://productimages.withfloats.com/actual/66618124c40ee9be019ac7b4.png", "tileimageuri": "https://productimages.withfloats.com/tile/66618124c40ee9be019ac7b4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:28:01.365Z", "updatedon": "2026-03-13T06:28:25.432Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//seizmet-gp-1-/1440", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET GP 1 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET GP 1", "Glimepiride (1mg)", "Metformin SR (500mg)", "Pioglitazone (15mg)", "Pioglitazone side effects", "Pioglitazone 15 mg price", "Pioglitazone uses", "Pioglitazone 30 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "glimepiride voglibose metformin", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/69abe998ad5b8f3f9ba863c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/69abe998ad5b8f3f9ba863c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2026-03-13T10:35:41.824Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-voglibose-metformin/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "DIABETIC RANGE", "tags": [ "glimepiride voglibose metformin tablets", "glimepiride voglibose metformin combination", "glimepiride voglibose metformin dosage", "glimepiride voglibose metformin uses", "glimepiride voglibose metformin composition", "glimepiride voglibose metformin tablets ip", "glimepiride voglibose metformin triple combination", "glimepiride voglibose metformin for type 2 diabetes", "triple drug combination for type 2 diabetes", "diabetes medicine for high fasting and pp sugar", "medicine for uncontrolled diabetes type 2", "combination tablets for diabetes management", "combination tablets for diabetes management", "when to take glimepiride voglibose metformin tablets", "who should take glimepiride voglibose metformin", "benefits of glimepiride voglibose metformin tablets", "side effects of glimepiride voglibose metformin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6825c6cc966e2a18bb4b35a6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Dapagliflozin 10mg and pioglitazone 15mg tablets", "description": "GLIDAPA PIO is a combination oral medication specially formulated to help manage type 2 diabetes mellitus. It combines two powerful antidiabetic agents, dapagliflozin and pioglitazone, to effectively control blood sugar levels. This medication is prescribed to patients when diet and exercise alone do not provide adequate glycemic control. By addressing blood glucose regulation through different mechanisms, GLIDAPA PIO helps reduce the risk of diabetes-related complications and supports overall metabolic health.\n\nKey Ingredients\nDapagliflozin (10mg): A sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar by increasing the excretion of glucose through urine.\n\nPioglitazone (15mg): A thiazolidinedione that improves insulin sensitivity by acting on fat, muscle, and liver cells, facilitating better glucose uptake and utilization.\n\nKey Benefits\nHelps maintain stable blood glucose levels in adults with type 2 diabetes.\n\nCombines two complementary mechanisms to enhance blood sugar control.\n\nSupports weight management due to dapagliflozin’s glucose excretion effect.\n\nMay improve insulin sensitivity and reduce insulin resistance.\n\nReduces the risk of diabetes-related complications such as cardiovascular problems when combined with lifestyle changes.\n\nConvenient once-daily tablet formulation.\n\nHow Does It Work?\nDapagliflozin blocks SGLT2 proteins in the kidneys, preventing glucose reabsorption and promoting its elimination through urine, which lowers blood glucose. Pioglitazone acts on insulin-responsive tissues, enhancing the body’s sensitivity to insulin. This dual action helps reduce both insulin resistance and excess blood glucose, providing better overall glycemic control. By targeting different pathways, GLIDAPA PIO offers a synergistic effect to manage type 2 diabetes more effectively.\n\nDirections for Use\nTake GLIDAPA PIO exactly as prescribed by your healthcare provider.\n\nUsually taken once daily, with or without food, at the same time each day.\n\nDo not skip doses or stop the medication without consulting your doctor.\n\nMaintain a balanced diet and regular exercise as advised alongside the medication.\n\nInform your doctor about any other medications you are taking to avoid potential interactions.\n\nSide Effects\nSome patients may experience side effects while taking GLIDAPA PIO, including:\n\nUrinary tract infections or increased urination due to dapagliflozin.\n\nWeight gain or swelling caused by pioglitazone.\n\nRisk of low blood sugar (hypoglycemia) when combined with other antidiabetic drugs.\n\nPossible dizziness or fatigue.\n\nRarely, heart failure or bladder cancer risk (associated with pioglitazone).\n\nIf you notice symptoms like excessive thirst, sudden weight gain, swelling, shortness of breath, or any allergic reactions, seek medical advice immediately.", "price": 255.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medication inform", "pioglitazone risk", "regular exercise", "balanced diet", "doctor maintain", "glucose uptake", "notice symptoms", "antidiabetic drugs", "swelling caused", "advised alongside", "skip doses", "healthcare provider", "effectively directions", "synergistic effect", "glycemic control", "cardiovascular problems", "complementary mechanisms", "fat muscle", "diabetesrelated complications", "insulin resistance", "bodys sensitivity", "glidapa pio", "urine pioglitazone 15mg", "taking glidapa pio", "bladder cancer risk", "improve insulin sensitivity", "improves insulin sensitivity", "glidapa pioglidapa pio", "dapagliflozin weight gain", "increased urination due", "urinary tract infections", "experience side effects", "insulinresponsive tissues enhancing", "liver cells facilitating" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2114, "imageuri": "https://productimages.withfloats.com/actual/6825c6ce65488af627fb2e46.png", "tileimageuri": "https://productimages.withfloats.com/tile/6825c6ce65488af627fb2e46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-15T10:49:48.361Z", "updatedon": "2026-03-13T10:20:54.654Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10mg-and-pioglitazone-15mg-tablets/2114", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": " GLIDAPA PIO", "category": "DIABETIC RANGE", "tags": [ "Dapagliflozin, pioglitazone combination", "Dapagliflozin, pioglitazone combination", "Dapagliflozin Pioglitazone CDSCO" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2026-03-26T05:46:52.891Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661adf866170d1ff8cb45d2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Teneligliptin 20mg, Pioglitazone 15mg & Extended Release Metformin Hydrochloride 500mg", "description": "TENELIGOLD PM 500 \nTeneligliptin 20mg, Pioglitazone 15mg & Extended Release Metformin Hydrochloride 500mg\n\nManaging type 2 diabetes requires the right combination of lifestyle habits, regular monitoring, and effective medication support. Teneligliptin 20 mg, pioglitazone 15 mg & extended-release metformin hydrochloride 500 mg is a powerful triple-combination medicine designed to help control blood sugar levels in adults with type 2 diabetes mellitus. This combination is often prescribed when a single medicine alone is not enough to achieve desired glucose control.\n\nIf you are searching for a trusted treatment option that works through multiple mechanisms, this medicine can be a practical choice under your doctor’s guidance. It helps improve insulin sensitivity, reduce excess glucose production, and support better post-meal sugar management.\n\nWhat is Teneligliptin 20mg, Pioglitazone 15mg & Extended Release Metformin Hydrochloride 500mg?\n\nThis medication combines three clinically proven anti-diabetic agents in one tablet:\n\nTeneligliptin 20mg – A DPP-4 inhibitor that helps increase insulin release after meals.\nPioglitazone 15mg – Improves the body’s sensitivity to insulin.\nExtended Release Metformin Hydrochloride 500mg – Reduces glucose production in the liver and improves insulin function with slow-release action.\n\nThis combination helps maintain stable blood sugar throughout the day while reducing sudden spikes after meals.\n\nHow Does It Work?\n1. Teneligliptin 20mg\n\nTeneligliptin works by blocking the DPP-4 enzyme. This increases incretin hormone levels, which stimulate insulin secretion when blood sugar rises and lower glucagon production.\n\n2. Pioglitazone 15mg\n\nPioglitazone helps cells become more responsive to insulin. This allows glucose to enter cells more efficiently and reduces insulin resistance.\n\n3. Extended-Release Metformin Hydrochloride 500mg\n\nMetformin ER decreases sugar production in the liver and slows intestinal absorption of glucose. The extended-release form provides smoother action and may reduce stomach discomfort.\n\nWhy Doctors Recommend This Combination\n\nFor many patients with type 2 diabetes, one medicine may not be enough over time. This triple-combination tablet is commonly recommended when:\n\nBlood sugar remains uncontrolled with metformin alone\nHbA1c levels stay above target\nInsulin resistance is significant\nPost-meal sugar spikes are frequent\nA simplified once-daily combination is preferred\nKey Benefits of Teneligliptin 20 mg Pioglitazone, 15mg & Extended Release Metformin Hydrochloride 500mg\nBetter Blood Sugar Control\n\nTargets fasting sugar, post-meal sugar, and long-term HbA1c levels.\n\nTriple Action Formula\n\nThree medicines in one tablet offer a broader treatment approach.\n\nImproves Insulin Sensitivity\n\nPioglitazone supports better glucose utilization in the body.\n\nConvenient Dosing\n\nOne combination tablet may reduce pill burden.\n\nExtended Release Comfort\n\nMetformin ER may be gentler on the stomach than regular metformin in some patients.\n\nSupports Long-Term Diabetes Management\n\nUseful for patients needing stronger sugar control under physician supervision.\n\nWho Can Benefit from This Medicine?\n\nThis medicine may be suitable for adults diagnosed with type 2 diabetes mellitus who need combination therapy. It is commonly used in patients who:\n\nHave uncontrolled diabetes despite diet and exercise\nNeed additional support beyond metformin\nWant easier medication compliance\nHave insulin resistance issues\n\nIt is not meant for type 1 diabetes or diabetic ketoacidosis.\n\nHow to Take It\n\nAlways use this medicine exactly as prescribed by your healthcare provider.\n\nGeneral usage tips:\n\nUsually taken once daily or as directed\nTake with meals to reduce stomach discomfort\nSwallow whole; do not crush or break ER tablets\nMaintain regular meal timing\nContinue exercise and diabetic diet plan\n\nNever change dosage without medical advice.\n\nCommon Side Effects\n\nLike all medicines, some side effects may occur. Most are mild and manageable.\n\nFrequently Reported Side Effects\nNausea\nStomach upset\nDiarrhea\nHeadache\nWeight gain\nMild swelling in legs or ankles\nLow appetite\nDizziness\n\nIf symptoms persist, consult your doctor.\n\nSerious Side Effects (Need Immediate Medical Help)\n\nSeek medical attention if you notice:\n\nSevere weakness\nDifficulty breathing\nUnusual swelling\nChest pain\nSevere abdominal pain\nPersistent vomiting\nSigns of low blood sugar\nYellowing of eyes or skin\nPrecautions Before Use\n\nBefore taking Teneligliptin 20mg, Pioglitazone 15mg & Extended Release Metformin Hydrochloride 500mg, inform your doctor if you have:\n\nKidney disease\nLiver disorder\nHeart failure\nBladder problems\nHistory of pancreatitis\nAlcohol dependency\nPregnancy or breastfeeding concerns\n\nRegular blood tests may be required during treatment.\n\nCan It Cause Low Blood Sugar?\n\nThis medicine alone has a lower risk of hypoglycemia compared with some diabetes drugs. However, low sugar can happen if combined with:\n\nInsulin\nSulfonylureas\nSkipped meals\nExcess exercise\nAlcohol intake\nSigns of Low Sugar\nSweating\nTrembling\nHunger\nConfusion\nFast heartbeat\n\nKeep glucose tablets or a sugary snack handy if advised.\n\nLifestyle Tips for Best Results\n\nMedicine works best when combined with healthy habits.\n\nFollow a Diabetic Diet\n\nChoose:\n\nWhole grains\nFiber-rich vegetables\nLean protein\nControlled carbohydrate portions\nExercise Regularly\n\nAt least 30 minutes daily walking or approved exercise.\n\nMonitor Blood Sugar\n\nCheck glucose levels regularly and maintain records.\n\nStay Hydrated\n\nDrink enough water unless restricted by your doctor.\n\nAvoid Smoking & Alcohol Excess\n\nThese can worsen diabetic complications.\n\nWhy Buyers Prefer Combination Tablets\n\nMany patients prefer combination diabetes tablets because:\n\nFewer tablets daily\nBetter adherence to treatment\nCost-effective compared to separate medicines\nEasier routine management\nMulti-target glucose control\nStorage Instructions\nStore in a cool, dry place\nKeep away from moisture\nProtect from direct sunlight\nKeep out of reach of children\nFrequently Asked Questions\nIs this medicine good for newly diagnosed diabetes?\n\nUsually prescribed when lifestyle changes or single-drug therapy is insufficient. Doctor decides based on sugar levels.\n\nCan I take it for a long time?\n\nYes, diabetes often requires long-term treatment, but only under regular medical supervision.\n\nDoes it help reduce HbA1c?\n\nYes, this combination is commonly used to lower HbA1c and improve overall glycemic control.\n\nCan I stop once sugar becomes normal?\n\nNo. Do not stop medicine without consulting your doctor.\n\nIs it safe for elderly patients?\n\nIt may be used depending on kidney, liver, and heart health. Dose adjustment may be needed.\n\nFinal Words\n\nIf you are looking for an effective and convenient treatment option for type 2 diabetes, Teneligliptin 20mg, Pioglitazone 15mg & Extended Release Metformin Hydrochloride 500mg can be a valuable solution. With triple-action support, improved insulin response, and extended-release comfort, it helps many patients achieve better glucose control.\n", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "meals", "500mg", "EMAIL", "cells", "drugs", "GLP-1", "liver", "glass", "water", "dosing", "muscle", "action", "doctor", "fasting", "response", "treatment", "management", "one tablet", "utilization", "information", "postprandial", "Pioglitazone", "Key Benefits", "fat) tissues", "sterisonline", "sterispharma", "instructions", "DPP-4 enzyme", "CALL/WHATSAPP", "TENELIGOLD PM", "Teneligliptin", "glucose uptake", "Administration", "typical dosage", "glucose control", "glucagon levels", "glucagon release", "incretin hormones", "insulin secretion", "sustained release", "medical condition", "dosage adjustments", "metabolic disorder", "glucose regulation", "peripheral tissues", "insulin resistance", "glucose production", "healthcare provider", "insulin sensitivity", "biguanide medication", "Reduced Side Effects", "comprehensive control", "combination medication", "DPP-4) inhibitor class", "dipeptidyl peptidase-4", "high blood sugar levels", "overall glycemic control", "type 2 diabetes mellitus", "meal) blood sugar levels", "Incretin Hormone Enhancement", "thiazolidinedione medication", "Extended-release formulations", "inadequate insulin production", "intestinal glucose absorption", "gastrointestinal side effects", "Comprehensive Glycemic Control", "immediate-release formulations", "Extended-Release Metformin Hydrochloride", "glucose-dependent insulinotropic peptide", "Extended Release Metformin Hydrochloride" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1481, "imageuri": "https://productimages.withfloats.com/actual/6661adfd637f8700d7ca4512.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661adfd637f8700d7ca4512.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:39:20.713Z", "updatedon": "2026-04-24T07:45:48.471Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//teneligliptin-20mg-pioglitazone-15mg-extended-release-metformin-hydrochloride-500mg/1481", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PM 500 ", "category": "DIABETIC RANGE", "tags": [ "Teneligliptin 20mg", "Pioglitazone 15mg", "Metformin Hydrochloride 500mg", "Teneligliptin Tablets 20 mg uses", "Teneligliptin 20 mg + Metformin 500", "Teneligliptin 20 mg side effects", "teneligliptin pioglitazone", "teneligliptin pioglitazone metformin", "teneligliptin pioglitazone 20 30", "teneligliptin pioglitazone combination", "teneligliptin pioglitazone brand name", "Teneligliptin 20mg Pioglitazone 15mg Metformin 500mg tablet", "Teneligliptin Pioglitazone Metformin ER tablet uses", "Buy Teneligliptin 20mg Pioglitazone 15mg Metformin 500mg", "Bulk order Teneligliptin Pioglitazone Metformin tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a844e69b8516f884cd22", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Oxalobacter Formigenes, Bifidobacterium Lactis, Lactobacillus Acidophilus & Bacillus Coagulans", "description": "OXABACTOR \nProduct Description: OXABACTOR is a scientifically formulated probiotic supplement designed to support digestive health, optimize gut microbiome balance, and promote the body’s natural detoxification processes. It combines four potent, clinically studied probiotic strains—Oxalobacter formigenes, Bifidobacterium lactis, Lactobacillus acidophilus, and Bacillus coagulans—each selected for its unique ability to influence gut ecology, digestive function, and overall wellness.\n\nThis multi-strain formulation works synergistically to help maintain a healthy intestinal environment, improve nutrient absorption, reduce gastrointestinal discomfort, and provide targeted support for conditions related to oxalates, inflammation, and dysbiosis. OXABACTOR is especially beneficial for individuals seeking a comprehensive probiotic strategy that addresses both digestive health and metabolic detoxification, particularly in relation to oxalate metabolism.\n\nWhat Are Oxalobacter formigenes, Bifidobacterium lactis, Lactobacillus acidophilus & Bacillus coagulans?\nUnderstanding each strain within OXABACTOR is essential to appreciating the full spectrum of benefits this product offers.\n\n1. Oxalobacter formigenes\nOxalobacter formigenes is a specialized, naturally occurring, Gram-negative anaerobic bacterium that plays a key role in the breakdown and elimination of oxalates—naturally occurring compounds found in many foods (e.g., spinach, nuts, tea, chocolate) and produced by the body as a metabolic byproduct.\n\nOxalates can contribute to the formation of calcium oxalate kidney stones, a common and painful health condition. Oxalobacter formigenes uses oxalates as its primary energy source, converting them into carbon dioxide and formic acid, which are then safely eliminated via the digestive tract. Because of this unique metabolic ability, O. formigenes is widely studied for its potential to help reduce urinary oxalate levels and support kidney stone prevention.\n\nThis strain does not commonly exist in high amounts in many modern diets and the overuse of antibiotics can significantly reduce its presence in the gut. Supplementation with O. formigenes is a targeted way to restore a key component of oxalate metabolism.\n\nKey Characteristics:\n\nAnaerobic (requires little to no oxygen)\nOxalate-dependent metabolism\nColonizes the colon, where oxalate degradation occurs\nPlays a direct role in reducing systemic oxalate load\n2. Bifidobacterium lactis\nBifidobacterium lactis is one of the most well-researched and widely used probiotic strains, known for its robust ability to colonize the human gastrointestinal tract. It belongs to the Bifidobacterium genus, which is abundant in the intestines of breastfed infants and is strongly associated with a healthy, balanced gut microbiome.\n\nB. lactis contributes to a variety of digestive and immune system benefits by producing lactic and acetic acids, which help lower intestinal pH, inhibit the growth of harmful bacteria, and foster a more favorable environment for beneficial microbes. It also enhances the production of short-chain fatty acids (SCFAs), which support gut barrier function, reduce inflammation, and improve bowel regularity.\n\nThis strain is particularly useful for individuals experiencing occasional constipation, diarrhea, or digestive discomfort, as it supports both stool consistency and frequency. B. lactis is also known for its ability to support immune function, making it a valuable component for overall health maintenance.\n\nKey Characteristics:\n\nAcid-tolerant and bile-resistant\nSupports regular bowel movements\nEnhances immune function\nProduces beneficial SCFAs\n3. Lactobacillus acidophilus\nLactobacillus acidophilus is one of the most recognizable and extensively studied probiotic strains in the world. It is a lactic acid-producing bacterium that thrives in the small intestine, where it plays a crucial role in supporting digestion, nutrient absorption, and immune health.\n\nL. acidophilus helps maintain a balanced gut microbiome by producing lactic acid, which inhibits the growth of pathogenic bacteria such as E. coli, Salmonella, and Candida. This strain also supports the digestion of lactose, making it beneficial for individuals with lactose intolerance or sensitivity to dairy products.\n\nIn addition to its digestive benefits, L. acidophilus contributes to the integrity of the intestinal lining, helping reduce gut permeability (often referred to as “leaky gut”) and supporting a more robust immune response. It is also associated with improvements in vaginal and urinary tract health, though the digestive and immune benefits are its primary known effects.\n\nKey Characteristics:\n\nThrives in the small intestine\nLactic acid-producing\nSupports lactose digestion\nEnhances gut barrier function and immune health\n4. Bacillus coagulans\nBacillus coagulans is a spore-forming probiotic strain that offers unique advantages compared to many traditional non-spore probiotics. Its ability to form a protective spore allows it to survive harsh stomach acid, bile, and processing environments, resulting in higher survivability and stability.\n\nOnce it reaches the intestines, B. coagulans activates and begins producing lactic acid, which supports a more acidic gut environment that helps neutralize harmful bacteria and fosters the growth of beneficial microbes. This strain is especially noted for its anti-inflammatory and gastrointestinal support properties, including relief from bloating, gas, abdominal pain, and irregular bowel habits.\n\nB. coagulans is also valued for its fast-acting effects, often providing noticeable improvements in digestive comfort and function within a shorter timeframe than some other probiotics. It is a popular choice for individuals with chronic digestive symptoms, including those associated with IBS (irritable bowel syndrome) and gut dysbiosis.\n\nKey Characteristics:\n\nSpore-forming and highly resistant to stomach acid\nFast-acting digestive support\nAnti-inflammatory effects\nSupports gut motility and comfort\nHow OXABACTOR Works\nOXABACTOR is formulated to deliver a multi-pronged approach to gut health by combining the targeted action of Oxalobacter formigenes with the broad-spectrum support of Bifidobacterium lactis, Lactobacillus acidophilus, and Bacillus coagulans. Together, these strains create a balanced ecosystem that supports:\n\nOxalate degradation, reducing the burden of oxalates that can contribute to kidney stone formation and other systemic health issues\nGut microbiome balance, improving the ratio of beneficial to harmful bacteria\nDigestive function, including enhanced motility, reduced bloating, and improved stool consistency\nGut barrier integrity, helping to protect against inflammation and leaky gut\nImmune modulation, supporting a more resilient immune response through a healthier gut environment\nThis combination makes OXABACTOR a versatile solution for individuals looking to improve both digestive comfort and metabolic health, particularly those with a history of kidney stone formation, oxalate sensitivity, or chronic gastrointestinal symptoms.\n\nKey Benefits of OXABACTOR\n1. Supports Oxalate Metabolism and Kidney Stone Prevention\nThe inclusion of Oxalobacter formigenes sets OXABACTOR apart from standard probiotic supplements. By actively degrading oxalates, it may help reduce urinary oxalate levels, which can be beneficial for individuals prone to calcium oxalate kidney stones. This targeted support is especially valuable for those who consume high-oxalate diets or who have experienced recurrent stones.\n\n2. Improves Digestive Comfort and Regularity\nWith Bifidobacterium lactis, Lactobacillus acidophilus, and Bacillus coagulans, OXABACTOR provides comprehensive digestive support. Users often experience reduced bloating, gas, abdominal pain, and irregular bowel movements. The combination of strains helps normalize stool consistency, frequency, and ease of elimination.\n\n3. Enhances Gut Barrier Function and Reduces Inflammation\nA healthy gut lining is essential for overall health, as it serves as the body’s first line of defense against toxins and pathogens. OXABACTOR supports gut barrier integrity, helping reduce inflammation, improve nutrient absorption, and protect against conditions associated with leaky gut.\n\n4. Promotes a Balanced Gut Microbiome\nAntibiotics, poor diet, stress, and environmental toxins can disrupt the gut microbiome. OXABACTOR helps restore and maintain a balanced microbial environment, promoting the growth of beneficial bacteria while inhibiting the overgrowth of harmful microbes.\n\n5. Boosts Immune System Function\nApproximately 70% of the immune system resides in the gut. By improving gut health, OXABACTOR indirectly supports immune function, helping the body respond more effectively to challenges and maintain overall wellness.\n\n6. Convenient and Stable Formulation\nThanks to the spore-forming nature of Bacillus coagulans, OXABACTOR offers excellent survivability through the digestive tract and maintains stability during storage. This makes it a reliable choice for individuals seeking consistent probiotic support without the need for refrigeration.\n\nRecommended Uses\nOXABACTOR is typically recommended for adults looking to:\n\nSupport digestive health and alleviate occasional gastrointestinal discomfort\nImprove bowel regularity and stool consistency\nReduce symptoms of bloating, gas, and abdominal pain\nSupport kidney stone prevention through oxalate metabolism\nPromote a balanced gut microbiome\nEnhance immune function\nImprove overall wellness and metabolic health\nThe typical dosage and usage instructions should be followed as directed on the product label or under the guidance of a healthcare provider, as individual needs can vary based on gut health status, diet, and overall health goals.\n\nPotential Side Effects\nWhile OXABACTOR is generally well-tolerated, some individuals may experience mild side effects, especially during the initial days of supplementation as the gut microbiome adjusts. These can include:\n\nBloating or gas\nMild abdominal cramping\nChanges in bowel habits (e.g., more frequent or looser stools)\nTemporary digestive discomfort\nThese effects are often short-lived and typically resolve as the body adapts to the new probiotic strains. In most cases, they are mild and do not require discontinuation of the product.\n\nPrecautions and Considerations:\n\nIndividuals with compromised immune systems (such as those undergoing chemotherapy, with severe immunodeficiency, or who have recently had gastrointestinal surgery) should consult a healthcare provider before using probiotics.\nPeople with short bowel syndrome or certain severe gastrointestinal conditions should seek medical advice prior to supplementation.\nPregnant or breastfeeding women should consult a healthcare professional before starting any new supplement.\nThose taking antibiotics may benefit from OXABACTOR, but it is often recommended to take probiotics a few hours apart from antibiotic doses to maximize effectiveness.\nIf persistent or severe symptoms occur, it is important to discontinue use and consult a healthcare provider to rule out other underlying issues.\n\nConclusion\nOXABACTOR is a powerful, multi-strain probiotic supplement that offers a comprehensive approach to digestive health, oxalate metabolism, and gut microbiome balance. By combining the specialized action of Oxalobacter formigenes with the broad digestive and immune support of Bifidobacterium lactis, Lactobacillus acidophilus, and Bacillus coagulans, OXABACTOR provides targeted benefits for individuals seeking relief from digestive discomfort, improved regularity, and enhanced metabolic health.", "price": 349.0, "discountamount": 105.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "risk", "ORDER", "Email", "product", "ability", "WhatsApp", "digestion", "OXABACTOR", "intestines", "probiotics", "gut health", "information", "sterispharma", "sterisonline", "excess oxalate", "immune function", "overall wellness", "digestive health", "probiotic strains", "overall well-being", "unique combination", "Bacillus Coagulans", "balanced gut flora", "nutrient absorption", "beneficial bacteria", "harsh stomach acids", "comprehensive support", "kidney stone formation", "Bifidobacterium Lactis", "Oxalobacter Formigenes", "spore-forming probiotic", "healthy digestive system", "Lactobacillus Acidophilus" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1475, "imageuri": "https://productimages.withfloats.com/actual/6661a84791652a93cbbe3fa3.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661a84791652a93cbbe3fa3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:15:00.348Z", "updatedon": "2026-03-12T12:39:13.004Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//oxalobacter-formigenes-bifidobacterium-lactis-lactobacillus-acidophilus-bacillus-coagulans/1475", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OXABACTOR ", "category": "NEPHROLOGYRANGE", "tags": [ "OXABACTOR", "Oxalobacter formigenes tablet", "Oxalobacter formigenes treatment", "Oxalobacter Formigenes", "Lactobacillus acidophilus", "Bacillus coagulans", "oxalobacter formigenes probiotic supplement for kidney stones", "kidney health probiotic with bifidobacterium lactis", "oxalate reducing probiotic capsules", "oxalobacter formigenes research based supplement", "buy oxalobacter formigenes probiotic online", "oxalobacter formigenes supplement price", "private label oxalate reducing probiotic", "kidney stone probiotic supplement purchase" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66616218a743fd235822082f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS M 500 ", "description": "PIOSTERIS M 500 \nPioglitazone & Metformin Sustained Release Tablet\nIntroduction to PIOSTERIS M 500\nPIOSTERIS M 500 is a combination medication that includes Pioglitazone and Metformin Hydrochloride (Sustained Release). This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Pioglitazone and Metformin, PIOSTERIS M 500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Pioglitazone and Metformin?\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that works by increasing the body's sensitivity to insulin. It helps lower blood sugar levels by making cells more responsive to insulin, enhancing glucose uptake in muscle and adipose tissue, and reducing hepatic glucose production.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of PIOSTERIS M 500\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: Pioglitazone helps improve the body's response to insulin, while Metformin enhances insulin sensitivity and reduces hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS M 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS M 500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nSustained Blood Sugar Control: The sustained-release formulation of Metformin ensures prolonged blood sugar control throughout the day, improving patient compliance and overall effectiveness.\nHow to Use PIOSTERIS M 500\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS M 500 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS M 500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-m-500-134243", "price": 118.0, "discountamount": 35.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "TZD", "day", "body", "Diet", "meals", "EMAIL", "cells", "water", "Order", "liver", "amount", "action", "muscle", "Support", "Overview", "readings", "patients", "biguanide", "one tablet", "full glass", "neuropathy", "Guidelines", "utilization", "retinopathy", "PIOSTERIS M", "Adjustments", "information", "Optimal Use", "Introduction", "best results", "Reduced Risk", "Pioglitazone", "sterisonline", "sterispharma", "CALL/WHATSAPP", "triglycerides", "Consistent Use", "treatment plan", "dual mechanism", "typical dosage", "adipose tissue", "lipid profiles", "Administration", "two medications", "Exercise Adjunct", "prolonged effect", "excellent adjunct", "multiple pathways", "thiazolidinedione", "glucose regulation", "Recommended Dosage", "patient compliance", "Insulin Sensitivity", "healthcare provider", "individual response", "Diabetes Management", "overall effectiveness", "HDL cholesterol levels", "cardiovascular disease", "combination medication", "Metformin Hydrochloride", "long-term complications", "lifestyle modifications", "complementary mechanisms", "type 2 diabetes mellitus", "Lipid Profile Improvement", "stable blood sugar levels", "peripheral glucose uptake", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "prolonged blood sugar control", "Sustained Blood Sugar Control", "comprehensive glycemic control", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Sustained Release Tablet", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1411, "imageuri": "https://productimages.withfloats.com/actual/6661621b9a0a3c2c0600b4ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661621b9a0a3c2c0600b4ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:15:36.695Z", "updatedon": "2026-03-13T07:24:49.63Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//piosteris-m-500-/1411", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS M 500 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS M 500", "Pioglitazone", "Metformin Sustained Release Tablet", "Metformin hydrochloride 500 mg", "Metformin SR 500 dosage", "Metformin Hydrochloride Tablets IP 500mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }